Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Bendas

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
FEBS Open Bio|March 4, 2017
The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cellsThomas Ross, Bastian Jakubzig, Manuel Grundmann, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lysophosphatidylcholine attenuates melanoma cell adhesion and migration dependent on the degree of fatty acid saturationThomas Ross, Sebastian Heuter, Martin Schlesinger, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2023
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosisPhilipp König, Roman Zhulenko, Eloy Suparman, et al.
Anticancer Research|January 10, 2014
How liposomal Cisplatin overcomes chemoresistance in ovarian tumour cellsDaniel Philipp Stölting, Michaela Borrmann, Martin Koch, et al.
Cell Death Discovery|October 6, 2025
Increased efficacy of PARP inhibitors against cisplatin-sensitive and -resistant ovarian cancer cells mediated via ATR and ATM inhibitionPhilipp König, Leon Bade, Julia Maria Eichhorn, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-SelectinSvenja Schwarz, Lukas Maria Gockel, Annamaria Naggi, et al.
International Journal of Antimicrobial Agents|February 11, 2011
Model membrane approaches to determine the role of calcium for the antimicrobial activity of friulimicinKatrin Reder-Christ, Hildegard Falkenstein-Paul, Gabriela Klocek, et al.
Molecules (Basel, Switzerland)|May 4, 2017
The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor ModelsThomas Mueller, Daniel Bastian Pfankuchen, Kathleen Wantoch von Rekowski, et al.
Plos One|January 19, 2018
The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formationJan Moritz Ponert, Svenja Schwarz, Reza Haschemi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 8, 2024
SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cellsPhilipp König, Julia Maria Eichhorn, Eloy Suparman, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
FEBS Open Bio|March 4, 2017
The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cellsThomas Ross, Bastian Jakubzig, Manuel Grundmann, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lysophosphatidylcholine attenuates melanoma cell adhesion and migration dependent on the degree of fatty acid saturationThomas Ross, Sebastian Heuter, Martin Schlesinger, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2023
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosisPhilipp König, Roman Zhulenko, Eloy Suparman, et al.
Anticancer Research|January 10, 2014
How liposomal Cisplatin overcomes chemoresistance in ovarian tumour cellsDaniel Philipp Stölting, Michaela Borrmann, Martin Koch, et al.
Cell Death Discovery|October 6, 2025
Increased efficacy of PARP inhibitors against cisplatin-sensitive and -resistant ovarian cancer cells mediated via ATR and ATM inhibitionPhilipp König, Leon Bade, Julia Maria Eichhorn, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-SelectinSvenja Schwarz, Lukas Maria Gockel, Annamaria Naggi, et al.
International Journal of Antimicrobial Agents|February 11, 2011
Model membrane approaches to determine the role of calcium for the antimicrobial activity of friulimicinKatrin Reder-Christ, Hildegard Falkenstein-Paul, Gabriela Klocek, et al.
Molecules (Basel, Switzerland)|May 4, 2017
The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor ModelsThomas Mueller, Daniel Bastian Pfankuchen, Kathleen Wantoch von Rekowski, et al.
Plos One|January 19, 2018
The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formationJan Moritz Ponert, Svenja Schwarz, Reza Haschemi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 8, 2024
SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cellsPhilipp König, Julia Maria Eichhorn, Eloy Suparman, et al.
Pageof 11